Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1978 1
1979 1
1980 4
1981 1
1983 2
1985 2
1987 3
1988 2
1989 3
1990 6
1991 8
1992 2
1993 4
1994 1
1995 7
1996 5
1997 9
1998 10
1999 10
2000 8
2001 8
2002 28
2003 27
2004 35
2005 43
2006 56
2007 74
2008 122
2009 153
2010 213
2011 320
2012 434
2013 731
2014 1087
2015 1419
2016 1921
2017 2335
2018 2828
2019 3793
2020 4747
2021 5476
2022 5787
2023 6214
2024 8009
2025 12134
2026 7416

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58,769 results

Results by year

Filters applied: . Clear all
Page 1
Microbiome therapeutics for hepatic encephalopathy.
Bloom PP, Tapper EB, Young VB, Lok AS. Bloom PP, et al. J Hepatol. 2021 Dec;75(6):1452-1464. doi: 10.1016/j.jhep.2021.08.004. Epub 2021 Aug 25. J Hepatol. 2021. PMID: 34453966 Free PMC article. Review.
Other microbiome therapeutics, including postbiotics and absorbents, have been used to target microbial products. ...However, there remain several challenges to the effective application of microbiome therapeutics in HE, including the resilience of the …
Other microbiome therapeutics, including postbiotics and absorbents, have been used to target microbial products. ...However, …
Microbiome-Based Therapeutics for Insomnia.
Li C, Chen S, Wang Y, Su Q. Li C, et al. Int J Mol Sci. 2024 Dec 9;25(23):13208. doi: 10.3390/ijms252313208. Int J Mol Sci. 2024. PMID: 39684918 Free PMC article. Review.
Given the significant global increase in insomnia and the growing scientific evidence connecting gut microbiota to this disorder, targeting gut microbiota as an intervention for insomnia has gained popularity. In this review, we summarize current microbiome-b …
Given the significant global increase in insomnia and the growing scientific evidence connecting gut microbiota to this disorder, tar …
Microbiome-based therapeutics for Parkinson's disease.
Hamilton AM, Krout IN, White AC, Sampson TR. Hamilton AM, et al. Neurotherapeutics. 2024 Oct;21(6):e00462. doi: 10.1016/j.neurot.2024.e00462. Epub 2024 Oct 11. Neurotherapeutics. 2024. PMID: 39393983 Free PMC article. Review.
Experimental models have bridged these associations toward defined contributions, identifying various microbiome-dependent impacts to PD pathology. These studies have laid the foundation for human translation, examining whether certain members of the microbiome and/ …
Experimental models have bridged these associations toward defined contributions, identifying various microbiome-dependent impacts to …
The human skin microbiome: from metagenomes to therapeutics.
Oh J, Voigt AY. Oh J, et al. Nat Rev Microbiol. 2025 Dec;23(12):771-787. doi: 10.1038/s41579-025-01211-9. Epub 2025 Aug 4. Nat Rev Microbiol. 2025. PMID: 40760050 Review.
In recent years, our understanding of the skin microbiome has expanded substantially with the deployment of metagenomic sequencing. This technology, by reconstructing microbial species, strains and gene pathways in the microbiomes of different cohorts, has led to id …
In recent years, our understanding of the skin microbiome has expanded substantially with the deployment of metagenomic sequencing. T …
Microbiome therapeutics for the treatment of recurrent Clostridioides difficile infection.
Bloom PP, Young VB. Bloom PP, et al. Expert Opin Biol Ther. 2023 Jan;23(1):89-101. doi: 10.1080/14712598.2022.2154600. Epub 2022 Dec 19. Expert Opin Biol Ther. 2023. PMID: 36536532 Review.
AREAS COVERED: This review covers the mechanisms by which microbiome therapeutics treat rCDI, their efficacy and safety, and clinical trial design considerations for future research. EXPERT OPINION: Altering the chemical environment of the gut and reconstituting col …
AREAS COVERED: This review covers the mechanisms by which microbiome therapeutics treat rCDI, their efficacy and safety, and c …
Long COVID and gut microbiome: insights into pathogenesis and therapeutics.
Lau RI, Su Q, Ng SC. Lau RI, et al. Gut Microbes. 2025 Dec;17(1):2457495. doi: 10.1080/19490976.2025.2457495. Epub 2025 Jan 24. Gut Microbes. 2025. PMID: 39854158 Free PMC article. Review.
Recent clinical trials have indicated that gut microbiome modulation using probiotics, prebiotics, and fecal microbiota transplantation (FMT) led to improvements in multiple symptoms related to PACS, including fatigue, memory loss, difficulty in concentration, gastr …
Recent clinical trials have indicated that gut microbiome modulation using probiotics, prebiotics, and fecal microbiota transp …
Microbiome-based therapeutics for ocular diseases.
Berzack S, Galor A. Berzack S, et al. Clin Exp Optom. 2025 Mar;108(2):115-122. doi: 10.1080/08164622.2024.2422479. Epub 2024 Dec 1. Clin Exp Optom. 2025. PMID: 39617011 Free PMC article. Review.
The relationship between the gut microbiome and ocular health has garnered increasing attention within the scientific community. ...This review synthesises current evidence on these associations, exploring how gut microbiome alterations drive disease mechanisms. Fur …
The relationship between the gut microbiome and ocular health has garnered increasing attention within the scientific community. ...T …
Microbiome Therapeutics for Clostridioides difficile Infection.
Lucky CW, Medernach RL, Kelly BJ, Kwon JH, Woodworth MH. Lucky CW, et al. Infect Dis Clin North Am. 2025 Dec;39(4):663-683. doi: 10.1016/j.idc.2025.07.007. Epub 2025 Aug 11. Infect Dis Clin North Am. 2025. PMID: 40796472 Free PMC article. Review.
Microbiota-based therapies are used increasingly for the treatment and prevention of Clostridioides difficile infection (CDI), particularly in cases of recurrent CDI (rCDI). This review discusses the different types of microbiota-based therapies, including fecal …
Microbiota-based therapies are used increasingly for the treatment and prevention of Clostridioides difficile infection (CDI), partic …
Immunological consequences of microbiome-based therapeutics.
Alam MZ, Maslanka JR, Abt MC. Alam MZ, et al. Front Immunol. 2023 Jan 12;13:1046472. doi: 10.3389/fimmu.2022.1046472. eCollection 2022. Front Immunol. 2023. PMID: 36713364 Free PMC article. Review.
A new series of next-generation microbiome-based therapies are being developed to treat these diseases by transplanting bacteria or bacterial-derived byproducts into a diseased individual to reset the recipient's microbiome and restore health. ...As novel …
A new series of next-generation microbiome-based therapies are being developed to treat these diseases by transplanting bacteria or b …
Lung microbiome: new insights into the pathogenesis of respiratory diseases.
Li R, Li J, Zhou X. Li R, et al. Signal Transduct Target Ther. 2024 Jan 17;9(1):19. doi: 10.1038/s41392-023-01722-y. Signal Transduct Target Ther. 2024. PMID: 38228603 Free PMC article. Review.
This up-to-date review retrospectively summarizes the lung microbiome's history, composition, and function. We focus on the interaction of the lung microbiome with the oropharynx and gut microbiome and emphasize the role it plays in the innate and adap …
This up-to-date review retrospectively summarizes the lung microbiome's history, composition, and function. We focus on the in …
58,769 results
You have reached the last available page of results. Please see the User Guide for more information.